Gainplan LLC Sage Therapeutics, Inc. Transaction History
Gainplan LLC
- $288 Million
- Q4 2024
A detailed history of Gainplan LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Gainplan LLC holds 12,500 shares of SAGE stock, worth $89,250. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,500Holding current value
$89,250% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding SAGE
# of Institutions
193Shares Held
45MCall Options Held
304KPut Options Held
117K-
Black Rock Inc. New York, NY5.22MShares$37.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$34.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$32.8 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$31.8 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$21.4 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $424M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...